Medical Properties Trust $MPT

Real Estate · NYSE

Russell 1000 Alabama
$1.75
+0.11 (+6.71%)
As of Nov 20, 2026, 4:05 PM EST · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Nov 3, 2026, the first target we tracked for MPT.

Medical Properties Trust (MPT) is trading up at $1.75 (+6.71%) on NYSE, as of the latest quote. It is a Russell 1000 constituent in the Real Estate sector.

Analyst price targets on MPT

One firm's current price target on Medical Properties Trust: $2.25 — 29% above the current $1.75. Each is tracked to its date and scored the same way a member's call is.

1 target, newest first. Open a row for its source and scoring.

DateNov 3, 2026 FirmBNP Paribas Exane RatingNeutral · lowers Targetat $2.02 · $2.25 +11% Horizonby Nov 2027 StatusOpen

Entry price $2.02, the close nearest Nov 3, 2026, when the target was reported; the target is +11% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.

Scoring Open: judged on the close on Nov 3, 2027.

Source BNP Paribas Exane downgrades Medical Properties Trust stock rating on tenant concerns Investing.com · Nov 3, 2026 · opens the publisher's site
BNP Paribas Exane downgraded Medical Properties Trust (NYSE:MPT) to Neutral from Outperform and lowered its price target to $2.25 from $5.00.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Medical Properties Trust revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$1.54B−$432.8M−$2.41BFY2016 revenue: $541.1MFY2016 net income: $225.0M · Net margin 41.6%'16FY2017 revenue: $704.7MFY2017 net income: $289.8M · Net margin 41.1%'17FY2018 revenue: $784.5MFY2018 net income: $1.02B · Net margin 129.6%'18FY2019 revenue: $854.2MFY2019 net income: $374.7M · Net margin 43.9%'19FY2020 revenue: $1.25BFY2020 net income: $431.4M · Net margin 34.5%'20FY2021 revenue: $1.54BFY2021 net income: $656.0M · Net margin 42.5%'21FY2022 revenue: $1.54BFY2022 net income: $902.6M · Net margin 58.5%'22FY2023 revenue: $871.8MFY2023 net income: −$556.5M · Net margin −63.8%'23FY2024 revenue: $995.5MFY2024 net income: −$2.41B · Net margin −242.1%'24FY2025 revenue: $972.0MFY2025 net income: −$277.0M · Net margin −28.5%'25−200%−100%0%100%FY2016 net margin: 41.6%FY2017 net margin: 41.1%FY2018 net margin: 129.6%FY2019 net margin: 43.9%FY2020 net margin: 34.5%FY2021 net margin: 42.5%FY2022 net margin: 58.5%FY2023 net margin: −63.8%FY2024 net margin: −242.1% (off the scale, which stops at −202.2%)FY2025 net margin: −28.5%
Medical Properties Trust annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$541.1M$704.7M$784.5M$854.2M$1.25B$1.54B$1.54B$871.8M$995.5M$972.0M
Growth (year over year)+22.5%+30.2%+11.3%+8.9%+46.2%+23.6%−0.1%−43.5%+14.2%−2.4%
Gross profit——$700.4M$686.0M$1.22B$1.44B$1.38B$761.7M$921.4M$881.7M
Gross margin——89.3%80.3%97.6%93.4%89.1%87.4%92.6%90.7%
Operating income$341.6M$485.6M————————
Operating margin63.1%68.9%————————
Net income$225.0M$289.8M$1.02B$374.7M$431.4M$656.0M$902.6M−$556.5M−$2.41B−$277.0M
Net margin41.6%41.1%129.6%43.9%34.5%42.5%58.5%−63.8%−242.1%−28.5%
EPS (diluted)$0.86$0.82$2.76$0.87$0.81$1.11$1.50−$0.93−$4.02−$0.46
Balance sheet
Cash and equivalents$83.2M$171.5M$820.9M$1.46B$549.9M$459.2M$235.7M$250.0M$332.3M$540.9M
Total assets$6.42B$9.02B$8.84B$14.5B$16.8B$20.5B$19.7B$18.3B$14.3B$15.0B
Total liabilities$3.17B$5.19B$4.28B$7.44B$9.49B$12.1B$11.1B$10.7B$9.46B$10.4B
Long-term debt$2.91B$4.90B$4.04B$7.02B$8.87B$11.3B$10.3B$10.1B$8.85B$9.70B
Shareholders' equity$3.25B$3.82B$4.55B$7.03B$7.34B$8.44B$8.59B$7.63B$4.83B$4.61B
Cash flow
Operating cash flow$263.8M$362.2M$449.1M$494.1M$617.6M$811.7M$739.0M$505.8M$245.5M$230.8M
Share buybacks——————$17.9M——$23.4M

From Medical Properties Trust's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Medical Properties Trust in the news

Nov 3, 2026 Investing.com BNP Paribas Exane downgrades Medical Properties Trust stock rating on tenant concerns Target

About Medical Properties Trust

Medical Properties Trust, Inc. (MPT), headquartered in Birmingham, Alabama, is a real estate investment trust that invests in healthcare facilities.

Source: Wikipedia — Medical Properties Trust

Headquarters
Birmingham, Alabama From SEC filings, Oct 2026

More Real Estate stocks

Browse all companies →